Discover Innovative Approaches to Cell Line Development
In this upcoming webinar, attendees will delve into the ways streamlined cell line development enhances biologics production efficiency while ensuring a seamless move to clinical manufacturing. Guest experts will introduce transposase-mediated integration technology to illustrate its advantages. They will discuss essential aspects such as regulatory compliance and maintaining product stability throughout the development process.
Addressing Challenges in Biotherapeutic Manufacturing
Efficient cell line development poses a significant challenge in biotherapeutic production. Establishing high-yield expression systems that ensure product quality and compliance with regulatory standards can greatly influence the timeline for product development and the overall success of the project. The shared insights from this webinar aim to address these hurdles effectively.
Advanced Strategies for Streamlined Development
This session will cover advanced strategies that optimize every aspect of cell line development and processing. Utilizing transposase-based expression technology allows for stable and non-random integration of multiple copies of expression constructs into CHO-K1 cells. By applying this method, accelerated timelines in development can be achieved without compromising structural integrity. The approach focuses on creating stable pools that produce consistently expressed product subunits, facilitating the early production of drug materials vital for preclinical studies.
Enhancing Collaboration Across Disciplines
The webinar will also highlight how integrated, end-to-end development strategies can speed up biologics programs, especially those targeting complex antigens. A multidisciplinary approach connecting various areas such as discovery, pharmacology, preclinical, and technical development is crucial. Attendees will learn about synchronized workflows between CHO cell line development and upstream processes, which can mitigate risks and improve technology transfer. This robust process begins with stable pools, ensuring the efficient generation of material suitable for early safety evaluations.
Expert Insights from Industry Leaders
Join Cláudia Soares, Lead Scientist at CDR-Life, and Lynn Webster, Senior Scientist at Cell Line Development within ATUM, as they share their expertise during the live webinar scheduled for a specific date and time in November. This session promises to be insightful for those interested in the latest advancements in cell line development.
Register for the Webinar
Don't miss the chance to gain valuable insights on how streamlined cell line development can lead to faster and more reliable biologics production. Register today for the free webinar and take the first step towards enhancing your approach to clinical manufacturing.
About Xtalks
Xtalks, driven by Honeycomb Worldwide Inc., is a premier provider of educational webinars and digital content that serves global communities in the life sciences, food, healthcare, and medical device sectors. Each year, many industry professionals—including those from pharmaceutical and biotech companies—rely on Xtalks for access to quality educational resources. Xtalks provides crucial updates on industry trends, regulations, and job opportunities, helping professionals stay informed and engaged with key issues through insights from leading experts.
Frequently Asked Questions
What will the webinar cover?
The webinar will discuss streamlined cell line development, focusing on transposase integration technology and its benefits for biologics production.
Who are the featured speakers?
The speakers include Cláudia Soares from CDR-Life and Lynn Webster from ATUM, both experts in the field of cell line development.
When will the webinar take place?
The webinar is scheduled for a specific date in November at 10 a.m. EST.
How can I register for the webinar?
You can register by visiting the dedicated registration page for the webinar.
What organization is hosting the webinar?
Xtalks is hosting the webinar, focusing on advancements in cell line development for biologics.
